2TW-14926-08109

2 vaccinations 6 coded responses 23 check-ins 6 free-text entries 6 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 631 / MO
Registered: 2021-03-02

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-01
Dose 1 — Pfizer-BioNTech
2021-03-02
Registered in v-safe
2021-03-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-03-03
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-03-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-15
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-22
Dose 2 — Pfizer-BioNTech
2021-03-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Diarrhea, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-03-23
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-03-29
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-04-05
Survey response — day 14, dose 2
MedDRA: Blister, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Blisters continue to form. Primarily on hands and fingers. · Healthcare visit (other): Doctor visit in person today

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Report sent to call center — day 14, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-12
Survey response — day 21, dose 2
MedDRA: Blister — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Blister-like lesions are still present.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Report sent to call center — day 21, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-19
Survey response — day 28, dose 2
MedDRA: Medical counselling, Skin lesion — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Hands continue to have lesions. They have not improved, in fact have spread. Seems to be mainly on hands and fingers. I plan to have an evaluation by a dermatologist. · Healthcare visit (other): Waiting for in person evaluation by dermatologist. Primary physician has suggested I have a biopsy by dermatologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-19
Report sent to call center — day 28, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-26
Survey response — day 35, dose 2
MedDRA: Eczema, Office visit, Skin lesion — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Eczema lesions on hands and fingers. · Healthcare visit (other): In person visit with dermatologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Report sent to call center — day 35, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-03
Survey response — day 42, dose 2
MedDRA: Unevaluable event — Feeling: Fair

Free text: Lesions remain though cortisone med continues to be applied. No improvement noted.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-16
Call 1 — Could Not Reach Participant
2021-06-21
Survey response — 3 months, dose 2
MedDRA: Diplopia, Migraine, Nausea, Office visit, Vomiting — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Migraine-like headache, nausea and vomiting, diplopia. · Healthcare visit (other): In person appointment with internist, MRI, in-personal ophthalmologist visit.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-21
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-21
Call 2 — Left Voicemail
2021-06-28
Call 3 — Left Voicemail
2021-09-20
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-03-22
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-01	Pfizer-BioNTech
2	2021-03-22	Pfizer-BioNTech

Call center

6 call center cases

6 unsuccessful

See the call center timeline

Free text

Release 6 — day 14, dose 2

2021-04-05

Symptoms: Blisters continue to form. Primarily on hands and fingers.

Healthcare visit (other): Doctor visit in person today

Release 7 — day 21, dose 2

2021-04-12

Symptoms: Blister-like lesions are still present.

Release 7 — day 28, dose 2

2021-04-19

Symptoms: Hands continue to have lesions. They have not improved, in fact have spread. Seems to be mainly on hands and fingers. I plan to have an evaluation by a dermatologist.

Healthcare visit (other): Waiting for in person evaluation by dermatologist. Primary physician has suggested I have a biopsy by dermatologist

Release 8 — day 35, dose 2

2021-04-26

Symptoms: Eczema lesions on hands and fingers.

Healthcare visit (other): In person visit with dermatologist

Release 8 — day 42, dose 2

2021-05-03

Symptoms: Lesions remain though cortisone med continues to be applied. No improvement noted.

Release 9 — 3 months, dose 2

2021-06-21

Symptoms: Migraine-like headache, nausea and vomiting, diplopia.

Healthcare visit (other): In person appointment with internist, MRI, in-personal ophthalmologist visit.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	✓	✓	✓
HCVO	Office visit	✓	✓	✓
SD	Blister	✓	✓	✓
SD	Diplopia	✓	✓	✓
SD	Eczema	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Skin lesion	✓	✓	✓
SD	Unevaluable event	✓	✓	✓
SD	Vomiting	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release